Spis treści:
Spis załącznikĂłw:
3JR_Financial_statements_Q1.zip (REPORT)
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załącznikĂłw:
3JR_Financial_statements_Q1.zip (REPORT)
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 21 | / | 2017 | ||||||||
| Date of issue: | 2017-04-28 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31 March 2017 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| 1. Financial Statements 2. Notes to the Financial Statements 3. Management report 4. Templates of the financial reports approved by the Bulgarian FSC 5. Declaration of the responsible directors 6. Insider information 7. Additional information 8. List of insider information under Art. 7 of Regulation (EU) 596/2014 |
|||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_Financial statements Q1.zip3JR_Financial statements Q1.zip | INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31 March 2017 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2017-04-28 | Ognian Donev | Executive director | |||